tiprankstipranks
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
Holding SPRY?
Track your performance easily

ARS Pharmaceuticals (SPRY) Technical Analysis

323 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
ARS Pharmaceuticals’s (SPRY) Moving Averages Convergence Divergence (MACD) indicator is -0.25, suggesting ARS Pharmaceuticals is a Buy.
ARS Pharmaceuticals’s (SPRY) 20-Day exponential moving average is 14.54, while ARS Pharmaceuticals’s (SPRY) share price is $14.51, making it a Sell.
ARS Pharmaceuticals’s (SPRY) 50-Day exponential moving average is 14.39, while ARS Pharmaceuticals’s (SPRY) share price is $14.51, making it a Buy.

ARS Pharmaceuticals (SPRY) Pivot Points

Dec 22, 2024, 07:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
13.43
13.80
14.16
14.53
14.90
15.27
15.63
Fibonacci
13.80
14.08
14.25
14.53
14.81
14.99
15.27
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

ARS Pharmaceuticals (SPRY) Moving Averages

Dec 22, 2024, 07:04 AM
Period
Simple
Exponential
MA5
14.22Buy
14.29Buy
MA10
13.96Buy
14.30Buy
MA20
14.83Sell
14.54Sell
MA50
14.82Sell
14.39Buy
MA100
13.37Buy
13.32Buy
MA200
11.11Buy
11.22Buy
ARS Pharmaceuticals’s (SPRY) 10-Day exponential moving average is 14.30, while ARS Pharmaceuticals’s (SPRY) share price is $14.51, making it a Buy.
ARS Pharmaceuticals’s (SPRY) 100-Day exponential moving average is 13.32, while ARS Pharmaceuticals’s (SPRY) share price is $14.51, making it a Buy.
ARS Pharmaceuticals’s (SPRY) stock price is $14.51 and ARS Pharmaceuticals’s (SPRY) 50-day simple moving average is 14.82, creating a Sell signal.
ARS Pharmaceuticals’s (SPRY) stock price is $14.51 and ARS Pharmaceuticals’s (SPRY) 100-day simple moving average is 13.37, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) stock price is $14.51 and ARS Pharmaceuticals’s (SPRY) 200-day simple moving average is 11.11, creating a Buy signal.

ARS Pharmaceuticals (SPRY) Technical Indicators

Dec 22, 2024, 07:04 AM
Name
Value
Implied Action
RSI (14)
49.12
Neutral
STOCH (9,6)
73.50
Neutral
STOCHRSI (14)
26.55
Neutral
MACD (12,26)
-0.25
Buy
ADX (14)
12.95
Buy
Williams %R
-72.73
Buy
CCI (14)
-19.30
Neutral
ATR (14)
0.96
-
Ultimate Oscillator
45.52
Neutral
ROC
-14.85
Sell
ARS Pharmaceuticals’s (SPRY) Relative Strength Index (RSI) is 49.12, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Trend Strength Indicator (ADX) is 12.95, creating a Buy signal.
ARS Pharmaceuticals’s (SPRY) Commodity Channel Index (CCI) is -19.30, creating a Neutral signal.
ARS Pharmaceuticals’s (SPRY) Price Rate of Change (ROC) is -14.85, creating a Sell signal.

FAQ

Is SPRY a Buy, Hold, or Sell?
Based on SPRY’s technical indicators, SPRY is a Buy.
    What is SPRY’s RSI (14)?
    SPRY’s RSI (14) is 49.12, which suggests SPRY is a Neutral.
      What is SPRY’s MACD?
      SPRY’s MACD is -0.25, which suggests SPRY is a Buy.
        What is SPRY’s 5-day moving average?
        SPRY’s 5-day moving average is 14.22, which suggests SPRY is a Buy.
          What is SPRY’s 20-day moving average?
          SPRY 20-day moving average is 14.83, which suggests SPRY is a Sell.
            What is SPRY’s 50-day moving average?
            SPRY’s 50-day moving average is 14.82, which suggests SPRY is a Sell.
              What is SPRY’s 200-day moving average?
              SPRY’s 200-day moving average is 11.11, which suggests SPRY is a Buy.
                What is SPRY’s Williams % R (14)?
                SPRY’s Williams % R (14) is -72.73, which suggests SPRY is a Buy.
                  What is SPRY’s CCI (14)?
                  SPRY’s CCI (14) is -19.30, which suggests SPRY is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis